๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chemoprevention of prostate cancer: The prostate cancer prevention trial

โœ Scribed by Thompson, Ian M.; Coltman, Charles A.; Crowley, John


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
67 KB
Volume
33
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the prostate contributes to the age-related risk of prostate cancer. METHODS. The Prostate Cancer Prevention Trial has completed randomization of over 18,000 healthy men to either finasteride or placebo. CONCLUSIONS. While the primary objective of this study is to determine whether finasteride can reduce the period prevalence of prostate cancer over a 7-year period, the biologic and data resources of this study will provide multiple opportunities to better understand this most common cancer in U.S. men.


๐Ÿ“œ SIMILAR VOLUMES


Cancer of the prostate
โœ Gerald P. Murphy ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB ๐Ÿ‘ 2 views
Staging of prostate cancer
โœ James E. Montie ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB ๐Ÿ‘ 2 views
Transurethral resection of the prostate
โœ Vito Pansadoro; Cora N. Sternberg; Francesco Depaula; Alberto Florio; Diana Gian ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 350 KB ๐Ÿ‘ 2 views

Demonstration of malignant cells in blood specimens collected during transurethral resection of the prostate (TURP) has implicated TURP in the dissemination of prostatic cancer. Of 153 patients who underwent radiation therapy for prostate cancer between January 1977 and June 1990 and were retrospect

Prevention of prostate-related cancers i
โœ Pollard, Morris ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 119 KB ๐Ÿ‘ 2 views

BACKGROUND. Since prostate cancer (PC) development involves a combination of genetic predisposition and promotional mechanisms, especially the metabolic conversion of testosterone to 5โฃ dihydrotestosterone (DHT) by 5โฃ reductase, how do mechanisms in man relate to prostate-seminal vesicle (P-SV) tumo

Unravelling the genetics of prostate can
โœ Edwards, Stephen M. ;Eeles, Rosalind A. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 127 KB ๐Ÿ‘ 1 views
Molecular cytogenetics of prostate cance
โœ Nina N. Nupponen; Tapio Visakorpi ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 205 KB ๐Ÿ‘ 2 views

Prostate cancer is the most common malignancy among men in Western industrialized countries. The molecular pathogenesis of the disease is poorly known. Over the past 10 years, chromosomal aberrations in prostate cancer have been studied with several techniques, such as loss of heterozygosity (LOH),